- Revenue 2024
- $11,095,696
- Expenses 2024
- $9,799,090
Program services were 74.3% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
As filed
- Subsection
- 03
- NTEE code
- H30
- Classification
- 1000
- Street
- 5515 SECURITY LN STE 1105
These codes are the IRS's own and are shown exactly as filed. What each one means is in the Business Master File documentation (opens in a new tab).
Group exemption
The central organization of an IRS group exemption (group number 5582), covering 1 subordinate organization. matched by us
The IRS lists each organization's group exemption number; we match a subordinate to its central organization by that number and the affiliation code the IRS assigns.
-
NFCR WESTERN CHAPTER
NATIONAL FOUNDATION FOR CANCER RESEARCH INC EIN 27-4528107 ROCKVILLE, MD
Mission and programs · 2024
Mission
SEE SCHEDULE O
Activities or mission (Part I)
TO SUPPORT CANCER RESEARCH AND PUBLIC EDUCATION RELATING TO PREVENTION, EARLIER DIAGNOSIS, BETTER TREATMENTS AND ULTIMATELY, A CURE FOR CANCER.
-
Scientific Advancement: In 2023-2024, NFCR funded 37 scientists conducting groundbreaking research across more than 15 cancer types. This investment fuels basic, translational, and clinical research, expanding the global knowledge base and accelerating new therapeutic approaches. Clinical Impact: NFCR-supported discoveries advanced 7 therapies into clinical trial phases (5 Phase 1, 2 Phase 2), bringing innovative treatments closer to patients in need. Innovation Translation: NFCR contributed to breakthroughs in liquid biopsy technologies for early detection and precision oncology approaches, supporting innovations that improve patient outcomes and inform prevention strategies. Public Health Outreach: In 2024, NFCR distributed over 250 Cancer Prevention Kits, directly reaching over 1000 individuals through about 100 community events nationwide. These resources empower the public to adopt cancer-preventive behaviors and pursue timely screenings. Marketing & Communications Impact: NFCR's marketing and communications strategies amplify the reach, engagement, and influence of our scientific funding and public health initiatives, ensuring that program results translate into broad awareness, donor action, and sustained mission support. Owned & social channels: NFCR runs an active content ecosystem, including a blog, and media gallery with two YouTube series (Making Sense of Science and Cancer-Fighting Lifestyle), the All Things CANCER podcast, and an email newsletter sign-up for ongoing education and donor stewardship. Public education assets: NFCR publishes accessible prevention resources, including the downloadable Cancer Prevention & Early Detection Kit and Cancer Screening Guidelines, which reinforce behavior change and early detection messaging. Thought leadership & convenings: The annual NFCR Global Summit & Award Ceremonies serve as a collaboration engine where "new partnerships form every year," expanding the impact of NFCR's science communications beyond owned channels. Fundraising communications tied to outcomes: Event communications (e.g., Daffodils & Diamonds) publicly report results linking storytelling to tangible support for research. Mission context for all outreach: NFCR consistently communicates scale and stewardship - $420M+ funded and 5.3M+ lifetime donors in progress/annual reports and "About" materials, anchoring all marketing in mission impact. Through global collaboration, NFCR is making unique impact on a new and accelerated path to cures. NFCR envisions a world without cancer!
Expenses $5,045,821 · Grants $3,614,953
-
NFCR provides the public with free materials containing valuable information on the most up-to-date cancer preventive measures, treatment options, and diagnostic tools. Our powerful message has been mailed annually to households, reaching over 235,000 email subscribers and tens of thousands of individuals through our social media channels (Twitter and Facebook) and through our website and blogs, helps to assure that fewer of today's healthy individuals will get cancer and more of today's cancer patients will become tomorrow's cancer survivors. Our public education materials include early cancer detection guide, cancer prevention kits, recipes for healthy living, electronic and printed newsletters, the latest cancer headlines, and in-depth online cancer information.
Expenses $2,232,674
As filed on the 2024 return. The filer continues this part on Schedule O, which is not shown here.
Officers and directors · 2024
As listed in Part VII of the 2024 return, in the order the filer printed them. Each return names its own; this is not a roster the organization keeps with us.
-
Sujuan BaSUJUAN BA
PRESIDENT/CEO
- Total calculated
- $557,229
- From this org
- $462,395
- From related orgs
- $0
- Other
- $94,834
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $461,207
- Bonus
- $0
- Other
- $1,188
- Deferred
- $69,000
- Nontaxable benefits
- $25,834
- Filer's total
- $557,229
-
Kwok LeungKWOK LEUNG
CFO/SECRETARY
- Total calculated
- $265,443
- From this org
- $231,444
- From related orgs
- $0
- Other
- $33,999
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $226,658
- Bonus
- $2,500
- Other
- $2,286
- Deferred
- $33,999
- Nontaxable benefits
- $0
- Filer's total
- $265,443
-
Brian WachtelBRIAN WACHTEL
CHIEF DEV OFFICER/EXEC. DIR
- Total calculated
- $188,755
- From this org
- $166,208
- From related orgs
- $0
- Other
- $22,547
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $164,063
- Bonus
- $1,875
- Other
- $270
- Deferred
- $22,547
- Nontaxable benefits
- $0
- Filer's total
- $188,755
-
Zeting WangZETING WANG
SENIOR DIR OF DIRECT RESPONSE
- Total calculated
- $136,099
- From this org
- $123,693
- From related orgs
- $0
- Other
- $12,406
- Hours/week
- 40
-
Alfred SlanetzALFRED SLANETZ
CHAIR OF THE BOARD
- Total calculated
- $0
- Hours/week
- 5
-
Brian Leyland-JonesBRIAN LEYLAND-JONES
TREASURER
- Total calculated
- $0
- Hours/week
- 2
-
Judith P BarnhardJUDITH P BARNHARD
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1.5
-
Karen BurkeKAREN BURKE
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Franklin Salisbury JrFRANKLIN SALISBURY JR
DIRECTOR (EFF 01/31/2024)
- Total calculated
- $0
- Hours/week
- 1
-
Silas DeaneSILAS DEANE
DIRECTOR (EFF 05/24/2024)
- Total calculated
- $0
- Hours/week
- 1
-
Padmakumar KaimalPADMAKUMAR KAIMAL
DIRECTOR (EFF 05/24/2024)
- Total calculated
- $0
- Hours/week
- 1
-
Lance KawaguchiLANCE KAWAGUCHI
DIRECTOR (THRU 01/26/2024)
- Total calculated
- $0
- Hours/week
- 1
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us. Earlier years are each on their own filing page.
Filings
-
2024
- Revenue
- $11,095,696
- Expenses
- $9,799,090
- Contributions
- $10,388,208
- Grants paid
- $3,614,953
-
2023
- Revenue
- $9,162,442
- Expenses
- $9,790,531
- Contributions
- $8,681,414
- Grants paid
- $3,445,964
-
2022
- Revenue
- $8,408,059
- Expenses
- $8,484,908
- Contributions
- $8,181,991
- Grants paid
- $2,285,179
The four totals the IRS asks for on Part I of the Form 990, as filed. A dash means the figure was not present on the return — not that it was zero.
Other returns filed
-
2024 · 990-T
- Revenue
- not reported
- Expenses
- not reported
- Assets (EOY)
- not reported
-
2023 · 990-T
- Revenue
- not reported
- Expenses
- not reported
- Assets (EOY)
- not reported
-
2022 · 990-T
- Revenue
- not reported
- Expenses
- not reported
- Assets (EOY)
- not reported
-
2021 · 990
- Revenue
- $10,081,253
- Expenses
- $10,194,507
- Assets (EOY)
- $12,143,234
-
2021 · 990-T
- Revenue
- not reported
- Expenses
- not reported
- Assets (EOY)
- not reported
-
2020 · 990
- Revenue
- $11,465,290
- Expenses
- $10,830,001
- Assets (EOY)
- $12,283,856
-
2020 · 990-T
- Revenue
- not reported
- Expenses
- not reported
- Assets (EOY)
- not reported
-
2019 · 990
- Revenue
- $10,937,905
- Expenses
- $14,532,374
- Assets (EOY)
- $10,554,744
-
2018 · 990
- Revenue
- $13,696,895
- Expenses
- $15,147,731
- Assets (EOY)
- $13,294,160
-
2017 · 990
- Revenue
- $12,958,645
- Expenses
- $13,432,400
- Assets (EOY)
- $14,949,937
Nonprofiteer parses Forms 990, 990-EZ and 990-PF, in a window of recent tax years. These returns are recorded from the IRS e-file index, so their figures were extracted by that index rather than read from the return here — treat them as a different source from the filings above, not as more of the same record. A dash means the index carries no figure; Form 990-T listings carry none at all. Showing the 10 most recent; the API carries the rest.
Grants made
-
$1,000,000
2022 collaboration
-
$870,000
2024 collaboration
-
$850,000
2023 collaboration
-
Ovarian Cancer Research Alliance
$500,000
2023 Research Grant
-
MASSACHUSETTS GENERAL HOSPITAL
$352,092
2024 RESEARCH CONTRACTS
-
MASSACHUSETTS GENERAL HOSPITAL
$268,242
2023 RESEARCH CONTRACTS
-
$260,000
2022 RESEARCH CONTRACTS
-
$250,000
2024 RESEARCH CONTRACTS
-
$230,000
2024 RESEARCH CONTRACTS
-
$220,041
2023 RESEARCH CONTRACTS
The 10 largest by cash amount. The API serves every itemized grant.
Grants received
-
OVARIAN CANCER RESEARCH FUND INC
$500,000
2023 RESEARCH GRANT
-
2023 CLINICAL TRIAL SUPPORT
-
2024 For grant recipient's exempt purposes
-
2023 general support
-
2023 For grant recipient's exempt purposes
-
2022 For grant recipient's exempt purposes
-
$43,243
2022 FIGHTING CANCER BY FUNDING HIGH-RISK, HIGH-IMPACT, AND POTENTIALLY HIGH-REWARD DISCOVERIES IN THE LABS AND TRANSFORMING THEM INTO LIFE-SAVING TREATMENTS FOR CANCER PATIENTS
-
2023 GENERAL SUPPORT
-
DONOR ADVISED CHARITABLE GIVING
$25,085
2024 HEALTH
-
BNY MELLON CHARITABLE GIFT FUND
$20,000
2023 TO FURTHER THE ORGANIZATION'S EXEMPT PURPOSE
The 10 largest by cash amount. The API serves every itemized grant.
Related organizations
From Schedule R Part II, where a filer lists the tax-exempt organizations it is related to by control. It does not record shared board members or money.
Declared on its 2024 return
-
501(C)3 · CANCER RSRCH · DC · controlled entity
California fundraising campaigns
Campaigns run by paid fundraisers, commercial coventurers and thrift stores naming this organization, as California published them. Both figures are as filed, and what the first one counts depends on the campaign type — a coventurer or a thrift store files its own sales rather than money collected for the charity. The 990 reports this only as a yearly total, never per campaign.
-
RUFFALO NOEL LEVITZ LLC
$124 raised
2024 Commercial Fundraiser
-$4,202 to charity
-
RUFFALO NOEL LEVITZ LLC
$154 raised
2023 Commercial Fundraiser
-$3,887 to charity
-
MERKLE GROUP INC.
$4,239,937 raised
2020 Commercial Fundraiser
$1,440,948 to charity
-
MERKLE GROUP INC.
$4,893,795 raised
2019 Commercial Fundraiser
$4,276,795 to charity
Amounts are as filed and do not add up: a commercial coventurer reports one promotion's whole gross once for each charity that shared in it. A campaign may also name more than one registered charity, in which case it appears on each.
Other IRS files
Auto-Revocation List
Not listed. The IRS publishes this list for organizations whose exemption was automatically revoked for failing to file for three consecutive years.
Publication 78
Listed as of 13 October 2026, under deductibility GROUP.
These are two separate IRS files on two separate schedules, shown as published and not reconciled with each other. Neither is a statement about whether a contribution is deductible today: 19,245 organizations appear in Publication 78 while the IRS's own revocation file lists them as currently revoked, more than half of those revoked before 2019. Absence from Publication 78 is evidence of nothing, and presence is not evidence either. Verify current status with the IRS before relying on it.
What this page reflects
The registration facts above come from the IRS Business Master File published 13 October 2026 and read 1 November 2026, for every organization at once. Returns through tax year 2024, the newest we have parsed for this organization.